Major health insurers are aggressively restructuring their portfolios by walking away from volatile, government-subsidized insurance lines…

TL;DR

Major health insurers are aggressively restructuring their portfolios by walking away from volatile, government-subsidized insurance lines to protect their underwriting margins. At the same time, state and federal lawmakers are refining their legal approaches to target the industry's highly integrated pharmacy benefit manager models. By shifting their focus to commercial employer plans and restructuring corporate divisions, payers are attempting to insulate their profits from escalating regulatory and public relations pressure.

The Strategic Retreat from Government-Regulated Insurance Risk

Major health insurers are actively shedding volatile, government-subsidized business lines to insulate their margins from public sector rate shocks and regulatory scrutiny. On April 30, 2026, Cigna announced a complete exit from the Affordable Care Act (ACA) individual exchanges, phasing out plans for 369,000 members across 11 states Cigna's Pivot to Evernorth and the De-Risked Commercial Employer Focus. This move follows its 2025 exit from the Medicare Advantage market and occurs alongside a newly initiated strategic review of its utilization and care management subsidiary, eviCore Cigna's Pivot to Evernorth and the De-Risked Commercial Employer Focus.

"Cigna is exiting the Affordable Care Act exchanges — and exploring a sale of its controversial claims review subsidiary — as the company continues to prune its portfolio to focus on pharmacy services and employer-sponsored plans." — Cigna's Pivot to Evernorth and the De-Risked Commercial Employer Focus, citing Healthcare Dive

This portfolio de-risking highlights a major transition toward capital-light, commercial services and away from highly regulated public markets. By eliminating exposure to federal subsidy expirations and medical utilization spikes, Cigna successfully drove its healthcare division's Medical Loss Ratio down to 79.8% in the first quarter of 2026 Cigna's Pivot to Evernorth and the De-Risked Commercial Employer Focus.

What to watch: Watch for whether other major commercial insurers follow Cigna's lead in abandoning ACA individual markets to stabilize their core underwriting margins.

Legal and Legislative Traps for Vertically Integrated PBMs

State legislators are rewriting their legal playbooks to structurally dismantle vertically integrated pharmacy benefit managers while sidestepping federal preemption shields. Following a temporary court injunction against Arkansas's Act 624—which attempted to ban pharmacy benefit managers (PBMs) from owning retail or specialty pharmacies—Tennessee introduced the Freedom, Access, and Integrity in Registered Pharmacy (FAIR Rx) Act PBM Vertical Integration: State Ownership Restrictions and the Tennessee Strategic Rewrite. This new bill seeks to achieve the same structural separation of PBMs and pharmacies but frames the restriction strictly around state licensing authority PBM Vertical Integration: State Ownership Restrictions and the Tennessee Strategic Rewrite.

"Specifically, the Fair Rx Act language explicitly states that the law regulates only the 'qualifications, licensure, ownership, and control of pharmacies as a condition of professional practice within the state'..." — PBM Vertical Integration: State Ownership Restrictions and the Tennessee Strategic Rewrite, citing Mintz

This legal shift is critical because it aims to bypass ERISA preemption defenses that vertically integrated insurers historically used to block state-level reforms. If Tennessee’s strategy of using professional licensing police powers succeeds in court, it will provide a highly replicable blueprint for states looking to force corporate divestitures of PBM-owned pharmacies.

What to watch: Watch for the U.S. Court of Appeals for the Eighth Circuit’s ruling on the Arkansas Act 624 appeal, which will set a major precedent for state-level ownership restrictions.

What surprised us

• Cigna is willingly walking away from hundreds of thousands of customers to protect its margins. While most corporate strategies favor customer acquisition, Cigna's decision to exit the ACA exchanges means letting go of 369,000 members across 11 states Cigna's Pivot to Evernorth and the De-Risked Commercial Employer Focus. This aggressively underscores a industry-wide realization that chasing government-sponsored volume is no longer worth the underwriting volatility.
• Prior authorization businesses are transitioning from profit centers to corporate liabilities. Long considered a key tool for controlling medical costs, claims utilization platforms are now major public relations targets. Cigna's decision to explore a sale or partnership for its eviCore subsidiary shows that the regulatory and reputational friction of prior authorization is beginning to outweigh its operational utility Cigna's Pivot to Evernorth and the De-Risked Commercial Employer Focus.
• State lawmakers are becoming highly sophisticated legal draftsmen to bypass ERISA. Rather than passing broad PBM billing or pricing regulations that consistently get struck down in federal courts, Tennessee's FAIR Rx Act specifically carves out pricing and benefit designs to focus entirely on state-level pharmacy licensure PBM Vertical Integration: State Ownership Restrictions and the Tennessee Strategic Rewrite. It is a clever, highly targeted pivot that treats corporate ownership as a professional licensing issue rather than an insurance administration issue.